Nick Kyrgios is facing a provisional suspension after testing positive for benzoylecgonine, a cocaine metabolite, during June's grass-court event in Mallorca. The length of any eventual ban hinges on whether the 2022 Wimbledon finalist can prove to the International Tennis Integrity Agency (ITIA) that he took the drug outside of competition, a distinction that could mean the difference between a ban of just one month and one lasting up to four years.

The 31-year-old Australian was deemed "in competition" in Stuttgart between 8-12 June and again in Mallorca on 21-22 June, when he submitted the positive sample after a first-round exit. If he can satisfy investigators the drug was taken before that window, no independent tribunal would be needed and, should he enter an ITIA-approved treatment programme, the ban could be as short as one month, potentially allowing him back from 4 September. Precedent varies: Britain's Dan Evans was banned for a year in 2017 under older rules, while Moroccan player Imran Sibille received just a one-month ban in 2025 after proving the drug was taken days before competing. Kyrgios has previously criticised the ITIA's treatment of Jannik Sinner and Iga Swiatek's doping cases as too lenient.